Is hyperoxia in early pediatric veno-veno extracorporeal life support associated with mortality?
The Journal of ExtraCorporeal Technology · 2025
DOI: 10.1051/ject/2024013 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of ExtraCorporeal Technology, 2025. Verfasst von Asaad G Beshish und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Cardiology, Emory University School of Medicine, Children's Healthcare of Atlanta, 1405 Clifton Rd, NE Atlanta,…. Hauptthemen laut MEDLINE: Hyperoxia, Extracorporeal Membrane Oxygenation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Data is limited regarding the effects of supraphysiologic blood oxygen tension (hyperoxia) in patients requiring extracorporeal life support (ECLS). We sought to evaluate the association between hyperoxia and outcomes in pediatric patients requiring veno-venous (VV) ECLS.
Methods
Retrospective single-center study at an academic children’s hospital, Children’s Healthcare of Atlanta, Emory University School of Medicine that included all patients 0–18 years who required VV-ECLS between 01/2014 and 12/2019.
Results
During the study period 110 VV-ECLS runs occurred in 110 patients. Using a receiver operating characteristic curve, a mean partial pressures of oxygen (PaO 2 ) of 122 mmHg in the first 48 hours of ECLS was determined to have the optimal discriminatory ability with regard to mortality (sensitivity 41% and specificity 86%). Of the VV-ECLS runs, 68 (61.8%) had PaO 2 > 122 mmHg (hyperoxia group). The hyperoxia group tended to be older (105.4 vs. 1.6 months, p = 0.001), had higher rates of hemorrhagic complications (69.6% vs. 25.3%, p = 0.0001), and higher mortality rate (57.9% vs. 19.5%, p = 0.002). Adjusting for confounders, the hyperoxia group had higher odds of mortality (OR: 7.97, 95% CI: 1.72–36.86, p = 0.0079).
Conclusion
Children exposed to hyperoxia during the first 48 h of VV-ECLS were 8 times more likely to die than those who were not after adjusting for confounders (age group, body surface area, and indication for ECLS). Multicenter and prospective evaluation of this modifiable risk factor is imperative to improving the care of this high-risk cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Cardiology, Emory University School of Medicine, Children's Healthcare of Atlanta, 1405 Clifton Rd, NE Atlanta, GA 30322, USA.
- Emory University School of Medicine, 100 Woodruff Circle, Atlanta, GA 30322, USA.
- Children's Healthcare of Atlanta, 1405 Clifton Rd, NE Atlanta, GA 30322, USA.
- ECMO and Advanced Technologies, Children's Healthcare of Atlanta, 1405 Clifton Rd, NE Atlanta, GA 30322, USA.
- Department of Surgery, Division of Cardiothoracic Surgery, Emory University School of Medicine, Children's Healthcare of Atlanta, 1405 Clifton Rd, NE Atlanta, GA 30322, USA.
ORCID-Profile: Asaad G Beshish
Zitieren
APA
Beshish, A. G., Rodriguez-Morales, P., Shamah, R., Qian, J., Keane-Lerner, K., Zinyandu, T., Davis, J., Rosenblum, J. M., & Viamonte, H. K. (2025). Is hyperoxia in early pediatric veno-veno extracorporeal life support associated with mortality?. The Journal of ExtraCorporeal Technology. https://doi.org/10.1051/ject/2024013
Vancouver
Beshish AG, Rodriguez-Morales P, Shamah R, Qian J, Keane-Lerner K, Zinyandu T, et al. Is hyperoxia in early pediatric veno-veno extracorporeal life support associated with mortality?. The Journal of ExtraCorporeal Technology. 2025. doi:10.1051/ject/2024013
BibTeX
@article{Beshish2025,
author = {Beshish, Asaad G and Rodriguez-Morales, Paola and Shamah, Rebecca and Qian, Joshua and Keane-Lerner, Kasey and Zinyandu, Tawanda and Davis, Joel and Rosenblum, Joshua M and Viamonte, Heather K},
title = {Is hyperoxia in early pediatric veno-veno extracorporeal life support associated with mortality?},
journal = {The Journal of ExtraCorporeal Technology},
year = {2025},
doi = {10.1051/ject/2024013}
}
EUVIMED